EXIT CONSOLE
Nilus Lab

Nilus Lab Zenith v31.0

In-Silico Simulation Platform | scVI-Based Cardiac Reprogramming
Simulation Only — Not a Clinical Trial
Clinical Protocol Framework

Virtual Trial Protocol Specification

Protocol Design Specification — Not Executed

Scientific Boundary & Diligence Disclosure

This interface displays prospective trial protocol parameters and cohort stratification designs for in silico evaluation. In silico clinical trials and digital twin cohort simulations have not been executed. No prospective patient outcomes, Kaplan-Meier survival curves, response rates, or therapeutic hazard ratios are computed or claimed.

Target Lineage
Cardiomyocyte Lineage Conversion

Evaluation of non-oncogenic factor combinations for lineage fidelity and electrical conduction integrity.

Trial Architecture
Adaptive In Silico Design

Protocol specifications include dosage interval pulsing (ON/OFF) and multi-factor safety thresholds.

Execution Status
Non-Executed Specification

All simulation engines and synthetic outcome generators have been decommissioned.